On August 27, 2025 Adcendo, a clinical-stage biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical need, reported that management will participate in five upcoming investor conferences in September (Press release, ADCendo, AUG 27, 2025, View Source [SID1234655628]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 2025 Biopharma Back-to-School Conference
Format: 1×1 meetings
Date: Tuesday, September 2, 2025
Location: Boston, MA

Wells Fargo 2025 Healthcare Conference
Format: Company presentation
Date: Wednesday, September 3, 2025
Time: 3:45 p.m. ET
Location: Boston, MA

Cantor Global Healthcare Conference
Format: 1×1 meetings
Date: Thursday, September 4, 2025
Location: New York, NY

Morgan Stanley 23rd Annual Global Healthcare Conference
Format: Company presentation
Date: Monday, September 8, 2025
Time: 1:50 p.m. ET
Location: New York, NY

Bank of America Healthcare Trailblazers Private Company Conference
Format: 1×1 meetings
Date: Wednesday, September 17, 2025
Location: Boston, MA